ATDC is an annual course designed to help healthcare providers caring for patients with diabetes, including but not limited to: endocrinologists/diabetes specialists, internists, pediatricians, family physicians, physician assistants, medical residents and fellows, nurse practitioners, nurses, dietitians, social workers, and certified diabetes educators.

Attendees will have an opportunity to interact with leaders in the field and participate in detailed question and answer sessions with the experts. For insulin-requiring patients with diabetes (especially type 1), there will be multiple plenaries on emerging diabetes technologies including: CGMs, pumps, hybrid-closed loop systems. Since hypoglycemia is a major concern for these patients, alternate ways to deliver insulin (inhaled and newer preparations of glucagon like: nasal or stable) will be discussed. Cardiovascular disease is commonly associated with long-standing diabetes (especially type 2 diabetes), emerging therapies like SGLT2 inhibitors, weekly GLP-1 analogs, and other dual-action GLP/GIP analogs will be discussed regarding their role in individualizing their role in type 2 diabetes.

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Check out the virtual event at ATDC